Status:
COMPLETED
Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians
Lead Sponsor:
GlaxoSmithKline
Conditions:
Dermatitis, Atopic
Eligibility:
All Genders
Up to 12 years
Brief Summary
this study has been request by french health authorities to evaluate the use of flixovate in infants and its place in the treatment pathway. this study has 2 main pbjectives: 1/ Evaluation of changes...
Eligibility Criteria
Inclusion
- Analysis of changes in share of prescriptions:
- Infants who received at least one prescription of topical steroids between 1st January 2010 and 31st December 2012.
- Infants aged 3 to 12 months on the day of prescription of topical steroids.
- Description of the conditions of use and patient profiles:
- Infants who received at least one prescription of topical steroids between 1st January 2010 and 31st December 2012.
- Infants aged 3 to 12 months on the day of prescription of topical steroids.
Exclusion
- none
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01920464
Start Date
April 1 2013
End Date
October 1 2013
Last Update
September 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.